Bigul

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2019.

PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 26, 2019, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019. Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company remains closed from Tuesday, October 1, 2019 till 48 hours after the results are made public on October 26, 2019. We request you to kindly take the same on record.
15-10-2019
Bigul

PFIZER LTD. - 500680 - Shareholding for the Period Ended September 30, 2019

Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
14-10-2019
Bigul

Pfizer Ltd - 500680 - Compliance Certificate - Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015

In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate given by the Practicing Company Secretary, M/s. Manish Ghia & Associates, for the half year ended September 30, 2019.
14-10-2019
Bigul

Pfizer Ltd - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated October 11, 2019, issued by Karvy Fintech Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2019. We request you to take the same on record.
14-10-2019
Bigul

PFIZER LTD. - 500680 - Compliance Certificate - Regulation 7(3) Of The SEBI (LODR) Regulations, 2015

In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate from the Company and the Registrar and Share Transfer Agent for the half year ended September 30, 2019.
14-10-2019
Bigul

Pfizer Ltd - 500680 - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 127262 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer
14-10-2019
Bigul

Biocon Biologics acquires research facility from Pfizer Healthcare

Biotechnology major Biocon on Tuesday said its subsidiary has acquired a Chennai-based biological research facility from Pfizer Healthcare for an und
24-09-2019
Bigul

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
16-09-2019
Bigul

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
16-09-2019
Bigul

PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Analyst Teleconference Meeting
28-08-2019
Next Page
Close

Let's Open Free Demat Account